 Silodosin

Silodosin (trade names Urief in Japan, Rapaflo in the US, and Silodyx in Europe) is a medication for the symptomatic treatment of benign prostatic hyperplasia (BPH).It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).